Therapeutics News and Research

RSS

Mouse-adapted virus model to study persistent COVID induced lung disease

Researchers develop a mouse model to identify early biomarkers and test countermeasures needed to detect and prevent PASC.

21 Feb 2022

Study offers new understanding of how the immune system reacts to COVID-19

Little has been known to date about how the immune system's natural killer (NK) cells detect which cells have been infected with SARS-CoV-2.

21 Feb 2022

Prime Minister sets out the Government's plans to live with and manage COVID

Vaccines will remain the first line of defense against Covid-19 as the Prime Minister sets out the Government's plans to live with and manage the virus.

21 Feb 2022

SARS-CoV-2 Omicron variant prompts system sciences and precision medicine

In a new review study, researchers aimed to describe the emergence of the Omicron variant, its structure, its impact on health and health systems, and the challenges that can be expected due to this variant.

21 Feb 2022

Molecular characteristics of SARS-CoV-2 variants enabling antibody escape

A new review paper published in PLoS Pathogens discusses the new variants and the structural mechanism underlying antibody-mediated neutralization as well as mutational antibody escape.

21 Feb 2022

The effect of COVID-19 vaccination on long COVID symptoms

Researchers assessed the effectiveness of COVID-19 vaccines in patients experiencing long COVID.

21 Feb 2022

Codiak's publication highlights the ability of exoASO-STAT6 to selectively target tumor-associated macrophages

Codiak BioSciences, Inc., a clinical-stage biopharmaceutical company pioneering the development of exosome-based therapeutics as a new class of medicines, today announced the online publication of a new manuscript, Exosome mediated genetic reprogramming of tumor associated macrophages by exoASO-STAT6 leads to potent monotherapy anti-tumor efficacy, in the American Association for the Advancement of Science's journal, Science Advances.

18 Feb 2022

Study reveals the structural, functional landscape of neutralizing antibodies against SARS-CoV-2 spike protein

The SARS-CoV-2 virus is continuously evolving and structural changes to the virus may impact the efficacy of antibody therapies and vaccines.

18 Feb 2022

New research shines light on mysterious dynamics that define the interplay between nerves and muscle

New research co-led by a University of Ottawa Faculty of Medicine professor is shedding light on some of the mysterious dynamics that define the interplay between nerves and muscle.

17 Feb 2022

New METPlatform allows researchers to test drugs for possible use in brain metastases

It is estimated that about a quarter of cancer patients are at risk of brain metastases, a rate that is increasing especially among those who suffer relapses after having undergone different cancer treatments.

17 Feb 2022

Treatment found to be safe, efficacious in improving insomnia and night sweats among midlife women

Hot flashes and night sweats are a common cause of insomnia among peri- and postmenopausal women. Hot flashes, night sweats and insomnia are all linked to reduced quality of life and distress.

17 Feb 2022

Fortis Life Sciences Highlights First Year Success

Fortis Life Sciences, a strategic platform company providing capital, expertise, and operational resources to grow founder-led life science companies, today announced highlights from its first year of operations.

From Fortis Life Sciences 17 Feb 2022

A novel consensus-based computational pipeline that reliably predicts hACE2-RBD binding affinity

Researchers developed a novel computational model to predict the binding affinity between the hACE2 receptor and the RBD of S protein of SARS-CoV-2.

17 Feb 2022

Study investigates what causes blood malignancies linked to gene therapy for sickle cell disease

Gene therapy trials for sickle cell disease have been showing great promise, even offering hope of a cure. But in early 2021, the trials ground to a halt after reports of blood malignancies in two people in a trial sponsored by bluebird bio.

16 Feb 2022

Study finds higher mortality rates among African children and adolescents hospitalized with COVID-19

African children and adolescents hospitalized with COVID-19 experience much higher mortality rates than Europeans or North Americans of the same age, according to a recently published study conducted by researchers from the Institute of Human Virology (IHV) at the University of Maryland School of Medicine (UMSOM) and the Institute of Human Virology Nigeria (IHVN).

16 Feb 2022

Therapeutics News and Research

Mouse-adapted virus model to study persistent COVID induced lung disease

Study offers new understanding of how the immune system reacts to COVID-19

Prime Minister sets out the Government's plans to live with and manage COVID

SARS-CoV-2 Omicron variant prompts system sciences and precision medicine

Molecular characteristics of SARS-CoV-2 variants enabling antibody escape

The effect of COVID-19 vaccination on long COVID symptoms

Codiak's publication highlights the ability of exoASO-STAT6 to selectively target tumor-associated macrophages

Study reveals the structural, functional landscape of neutralizing antibodies against SARS-CoV-2 spike protein

New research shines light on mysterious dynamics that define the interplay between nerves and muscle

New METPlatform allows researchers to test drugs for possible use in brain metastases

Treatment found to be safe, efficacious in improving insomnia and night sweats among midlife women

Fortis Life Sciences Highlights First Year Success

A novel consensus-based computational pipeline that reliably predicts hACE2-RBD binding affinity

Study investigates what causes blood malignancies linked to gene therapy for sickle cell disease

Study finds higher mortality rates among African children and adolescents hospitalized with COVID-19

New cholera vaccine generates long-lasting antibody responses in mice

Human nose organoids provide better understanding of the first steps toward SARS-CoV-2 infection

Prediction of SARS-CoV-2 epitope candidates for future vaccines

The in vitro selection of a remdesivir-resistant SARS-CoV-2 mutation

Researchers create a comprehensive atlas of cerebrovascular cell types

Industry Focus eBook - Cell biology (5th edition) eBook

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Latest News